Safety and Efficacy of Multiple EPO Injections in Children With Cerebral Palsy
NCT03303573 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 164
Last updated 2017-10-10
Summary
This study is a retrospective review on the safety and efficacy of repetitive erythropoietin injection in children with cerebral palsy
Conditions
- Cerebral Palsy
Interventions
- DRUG
-
recombinant human erythropoietin
Subcutaneous rhEPO injection
Sponsors & Collaborators
-
Bundang CHA Hospital
lead OTHER
Eligibility
- Sex
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-01
- Primary Completion
- 2016-11-30
- Completion
- 2017-08-31
More Related Trials
-
Effect of Erythropoietin on Neurodevelopmental Outcomes in Very Preterm Infants With Intraventricular Hemorrhage
NCT03914690 ·Status: COMPLETED ·Phase: PHASE2
-
High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study
NCT00589953 ·Status: TERMINATED ·Phase: PHASE2
-
The Treatment of Premature Infants With Brain Injury by Autologous Umbilical Cord Blood Stem Cells
NCT03696745 ·Status: UNKNOWN ·Phase: PHASE1
-
Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants
NCT02076373 ·Status: UNKNOWN ·Phase: PHASE3
-
Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants
NCT00910234 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Long Term Effects of Erythropoietin in Patients With Moderate to Severe Traumatic Brain Injury
NCT03061565 ·Status: COMPLETED
-
High-dose Erythropoietin for Asphyxia and Encephalopathy
NCT02811263 ·Status: COMPLETED ·Phase: PHASE3
-
Erythropoietin Protects Very Preterm Infants Against Necrotizing Enterocolitis
NCT03919500 ·Status: COMPLETED ·Phase: PHASE2
-
Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy
NCT02256618 ·Status: COMPLETED ·Phase: PHASE1
-
Erythropoietin in Management of Neonatal Hypoxic Ischemic Encephalopathy
NCT03163589 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety Study of Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Traumatic Brain Injury: Dosing Tier 1
NCT01239706 ·Status: UNKNOWN ·Phase: PHASE2
-
PAEAN - Erythropoietin for Hypoxic Ischaemic Encephalopathy in Newborns
NCT03079167 ·Status: COMPLETED ·Phase: PHASE3
-
Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial)
NCT05395195 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of Recombinant Erythropoietin on Numbers of Circulating Endothelial Progenitor Cells in People With Persistent Symptoms During the Subacute Period After Traumatic Brain Injury
NCT02226848 ·Status: WITHDRAWN ·Phase: PHASE2
-
Erythropoietin in Traumatic Brain Injury (EPO-TBI)
NCT00987454 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Recombinant Human EPO on the Postoperative Neurologic Outcome in Pediatric Moyamoya Patients
NCT03882060 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy of Erythropoietin to Improve Survival and Neurological Outcome in Hypoxic Ischemic Encephalopathy
NCT01732146 ·Status: COMPLETED ·Phase: PHASE3
-
Recombinant Human Erythropoietin Compared to Autologous Pre-Donation Prior to Scoliosis Surgery in Children.
NCT00323752 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Feasibility Trial Protocol of Metformin in Infants After Perinatal Brain Injury
NCT06429007 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Effect of Recombinant Erythropoietin on Numbers of Circulating Endothelial Progenitor Cells in Subacute TBI
NCT02148367 ·Status: WITHDRAWN ·Phase: PHASE2
-
Neonatal Erythropoietin in Asphyxiated Term Newborns
NCT00719407 ·Status: COMPLETED ·Phase: PHASE1
-
Erythropoietin in HIE Neonate
NCT06590155 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Recombinant Human Erythropoietin Improve Neurodevelopmental Outcomes in Extremely Preterm Infants
NCT02745990 ·Status: UNKNOWN ·Phase: NA
-
Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity
NCT00339001 ·Status: UNKNOWN
-
Hydroxyurea Therapy for Neurological and Cognitive Protection in Pediatric Sickle Cell Anemia in Uganda ( BRAINSAFE-II )
NCT04750707 ·Status: COMPLETED ·Phase: PHASE3